BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Philip M, Augustine P, Thomas V, Ramesh GN, Vinayakumar KR, Ramachandran TM, Siyad I, Mukkada RJ, Devi RS, Chettupuzha AP, Jaison VA, Ramesh M, Mahadevan P, Koshy A; Kerala Inflammatory Bowel Disease Study Group. Multi-center prospective survey of inflammatory bowel diseases in Kerala: More than 2000 cases. Indian J Gastroenterol 2017;36:459-67. [PMID: 29368189 DOI: 10.1007/s12664-017-0809-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Banerjee R, Pal P, Nugent Z, Ganesh G, Adigopula B, Pendyala S, Bernstein CN. IBD in India: Similar Phenotype but Different Demographics Than the West. Journal of Clinical Gastroenterology 2020;54:725-32. [DOI: 10.1097/mcg.0000000000001282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rivera ED, Coffey JC, Walsh D, Ehrenpreis ED. The Mesentery, Systemic Inflammation, and Crohn’s Disease. Inflammatory Bowel Diseases 2019;25:226-34. [DOI: 10.1093/ibd/izy201] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
3 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Reference Citation Analysis]
4 Rawal KK, Shukla VP, Chikani S, Thakkar M, Ruparelia M, Chudasama RK. Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors. Indian J Gastroenterol 2021. [PMID: 34569013 DOI: 10.1007/s12664-021-01181-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Banerjee R, Pal P, Mak JWY, Ng SC. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1076-88. [PMID: 33181087 DOI: 10.1016/S2468-1253(20)30299-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Ghoshal UC, Rai S, Kulkarni A, Gupta A. Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligence. JGH Open. 2020;4:889-897. [PMID: 33102760 DOI: 10.1002/jgh3.12342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wei S, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology 2021;15:275-89. [DOI: 10.1080/17474124.2021.1840976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Thomas S, Hoxha K, Alexander W, Gilligan J, Dilbarova R, Whittaker K, Kossenkov A, Prendergast GC, Mullin JM. Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis. J Cell Biochem 2019;120:4225-37. [PMID: 30269357 DOI: 10.1002/jcb.27716] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 Dalzell AM, Ba’ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 2019;39:48-58. [DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]